Dosing & Uses
Urinary Tract Infection
Pending FDA approval for treatment of complicated urinary tract infections (cUTI), including acute pyelonephritis
Next:
Pharmacology
Mechanism of Action
Cefepime: Fourth-generation cephalosporin, beta-lactam antibiotic with clinical utility against susceptible gram-negative and gram-positive bacteria
Taniborbactam: Beta-lactamase inhibitor with potential treatment option for serious bacterial infections caused by difficult-to-treat drug resistant gram-negative bacteria, most notably carbapenem-resistant Enterobacterales (CRE) and carbapenem-resistant Pseudomonas aeruginosa (CRPA)
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
